Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer

被引:39
|
作者
Watanabe, S [1 ]
Asamura, H [1 ]
Suzuki, K [1 ]
Tsuchiya, R [1 ]
机构
[1] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan
来源
ANNALS OF THORACIC SURGERY | 2005年 / 79卷 / 05期
关键词
D O I
10.1016/j.athoracsur.2004.11.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Clinical diagnosis of the nodal status is a significant factor in determining the treatment and predicting the prognosis in lung cancer patients. A patient with clinical N1 (cN1) disease is usually considered to be a candidate for surgical intervention in the present staging system in non-small cell lung cancer (NSCLC). However, cN1 disease is a subset for which the method of treatment and surgical results are variable, simply because both upstaging and downstaging can occur. We evaluated the surgical and pathologic results of cN1 NSCLC patients to reveal the problems in diagnosis and surgical management for this subset. Methods. From January 1998 to March 2003, 1,606 patients underwent thoracotomy for primary lung cancer at the National Cancer Center Hospital. Among them, the subjects for this study were 168 (10.5%) NSCLC patients who were clinically diagnosed as having N1 disease and underwent surgery without induction therapy. Results. The tumor cell types of these 168 cN1 NSCLC patients were adenocarcinoma in 73 (44%) and squamous cell carcinoma in 79 (47%). Pneumonectomy was performed in 26% (n = 43) patients, bilobectomy in 15% (n = 25), and exploratory thoracotomy in 11% (n = 19). Of 19 exploratory thoracotomy cases, 10 cases were due to pleural dissemination. The pathologic nodal status of the 135 patients who underwent pulmonary resection and mediastinal dissection was pN0, 19% (n = 25); pN1, 44% (n = 59); and pN2-3, 37% (n = 51). Of the 55 adenocarcinomas, 60% (n = 33) were revealed to be N2 disease on pathologic examination. There were no significant differences in the serum tumor markers between the pN1 and pN2 groups. Among the 25 patients who were down-staged postoperatively (cN1-pN0), 21 patients (84%) showed obstructive pneumonia in the lung. Conclusions. In the staging process of cN1 disease, it will be helpful to perform mediastinoscopy and thoracoscopy to avoid unnecessary thoracotomy especially in adenocarcinoma, even though mediastinal nodes and pleural dissemination were negative on computed tomography investigation. Since extensive pulmonary resection (bilobectomy or pneumonectomy) was required in 41% of the patients, preoperative detailed cardiopulmonary function tests should be mandatory to reduce surgical morbidity and mortality. On the other hand, when pneumonia due to airway obstruction by the tumor exists, false-positive hilar nodes can be expected. (c) 2005 by The Society of Thoracic Surgeons.
引用
收藏
页码:1682 / 1685
页数:4
相关论文
共 50 条
  • [1] Outcome of Surgical Treatment for Clinical N1 Non-Small Cell Lung Cancer
    Nemoto, D.
    Ito, H.
    Tsuboi, T.
    Eriguchi, D.
    Samejima, J.
    Nagashima, T.
    Nakayama, H.
    Masuda, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S909 - S909
  • [2] Heterogeneity of Clinical N1 Non-Small Cell Lung Cancer
    Kim, Dohun
    Choi, Yong Soo
    Kim, Hong Kwan
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2014, 62 (02): : 103 - 108
  • [3] Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer
    Hishida, T.
    Yoshida, J.
    Nishimura, M.
    Nishiwaki, Y.
    Nagai, K.
    [J]. THORAX, 2008, 63 (06) : 526 - 531
  • [4] Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis
    Miyoshi, Kei
    Mimura, Takeshi
    Iwanaga, Koichiro
    Adachi, Shuji
    Tsubota, Noriaki
    Okada, Morihito
    [J]. SURGERY TODAY, 2010, 40 (05) : 428 - 432
  • [5] Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis
    Kei Miyoshi
    Takeshi Mimura
    Koichiro Iwanaga
    Shuji Adachi
    Noriaki Tsubota
    Morihito Okada
    [J]. Surgery Today, 2010, 40 : 428 - 432
  • [6] Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
    Bostantzoglou, Clementine
    Iliopoulou, Marianthi
    Hardavella, Georgia
    [J]. BREATHE, 2018, 14 (04) : 342 - 344
  • [7] Prognostic factors after surgical resection of N1 non-small cell lung cancer
    Mordant, P.
    Pricopi, C.
    Legras, A.
    Arame, A.
    Foucault, C.
    Dujon, A.
    Le Pimpec-Barthes, F.
    Riquet, M.
    [J]. EJSO, 2015, 41 (05): : 696 - 701
  • [8] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Masaya Tamura
    Isao Matsumoto
    Yusuke Tanaka
    Daisuke Saito
    Shuhei Yoshida
    Munehisa Takata
    Hirofumi Takemura
    [J]. General Thoracic and Cardiovascular Surgery, 2020, 68 : 261 - 265
  • [9] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Tamura, Masaya
    Matsumoto, Isao
    Tanaka, Yusuke
    Saito, Daisuke
    Yoshida, Shuhei
    Takata, Munehisa
    Takemura, Hirofumi
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (03) : 261 - 265
  • [10] Definitive Hypofractionated Radiation in the Treatment of Clinical N1 Non-Small Cell Lung Cancer (NSCLC)
    Gits, Colton C.
    Rehman, Sana
    Roach, Michael C.
    Speirs, Christina K.
    Chundury, Anupama
    Henke, Lauren
    Mullen, Daniel
    DeWees, Todd
    Bradley, Jeffrey D.
    Robinson, Clifford G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E37 - E37